Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
DXCM DexCom, Inc. daily Stock Chart
DXCM [NASD]
DexCom, Inc.
Healthcare | Medical Laboratories & Research | USA
statements
Index- P/E240.77 EPS (ttm)1.08 Insider Own0.90% Shs Outstand91.70M Perf Week-0.84%
Market Cap23.91B Forward P/E85.07 EPS next Y3.07 Insider Trans-23.10% Shs Float91.20M Perf Month-9.14%
Income101.10M PEG4.41 EPS next Q0.16 Inst Own- Short Float4.87% Perf Quarter19.23%
Sales1.48B P/S16.20 EPS this Y175.80% Inst Trans-0.71% Short Ratio3.83 Perf Half Y65.65%
Book/sh9.62 P/B27.10 EPS next Y38.25% ROA4.70% Target Price286.87 Perf Year122.56%
Cash/sh16.72 P/C15.59 EPS next 5Y54.60% ROE13.50% 52W Range107.44 - 306.71 Perf YTD19.21%
Dividend- P/FCF177.78 EPS past 5Y41.50% ROI7.10% 52W High-14.98% Beta0.68
Dividend %- Quick Ratio5.10 Sales past 5Y41.60% Gross Margin64.10% 52W Low142.69% ATR22.38
Employees3900 Current Ratio5.50 Sales Q/Q36.90% Oper. Margin9.60% RSI (14)54.52 Volatility6.91% 10.32%
OptionableYes Debt/Eq1.22 EPS Q/Q149.40% Profit Margin6.80% Rel Volume0.93 Prev Close266.38
ShortableYes LT Debt/Eq1.22 EarningsFeb 13 AMC Payout0.00% Avg Volume1.16M Price260.75
Recom1.60 SMA207.49% SMA502.58% SMA20032.94% Volume1,076,498 Change-2.11%
Mar-05-20Initiated Citigroup Buy $330
Nov-07-19Upgrade Guggenheim Neutral → Buy
Nov-07-19Reiterated Canaccord Genuity Buy $185 → $195
Oct-23-19Initiated Stifel Buy
Nov-28-18Initiated UBS Neutral $135
Oct-19-18Upgrade Goldman Sell → Neutral
Sep-12-18Upgrade Northland Capital Under Perform → Market Perform
Aug-02-18Reiterated Canaccord Genuity Buy $105 → $125
Jul-02-18Upgrade Raymond James Mkt Perform → Outperform
Jun-08-18Upgrade JP Morgan Neutral → Overweight
May-11-18Initiated BofA/Merrill Buy $100
May-03-18Reiterated Canaccord Genuity Buy $81 → $85
Apr-04-18Initiated Guggenheim Neutral
Apr-04-18Initiated Goldman Sell $57
Mar-23-18Upgrade Robert W. Baird Neutral → Outperform
Jan-04-18Downgrade Northland Capital Market Perform → Under Perform
Sep-28-17Reiterated Wedbush Outperform $85 → $76
Sep-28-17Downgrade Raymond James Outperform → Mkt Perform
Sep-28-17Downgrade Northland Capital Outperform → Market Perform
Sep-28-17Downgrade JP Morgan Overweight → Neutral
Apr-03-20 12:10PM  Will DexCom (DXCM) Beat Estimates Again in Its Next Earnings Report? Zacks
08:09AM  Dow Jones Futures: After Strong Market Rally, Tesla Leaps On Q1 Deliveries; Two Leaders Eye New Buy Points Investor's Business Daily
Apr-02-20 08:30AM  Dexcom Schedules First Quarter 2020 Earnings Release and Conference Call for April 28, 2020 at 4:30 p.m. Eastern Time Business Wire
Mar-31-20 04:52PM  5 Guru Stocks That Beat the Market GuruFocus.com
08:11AM  Here's Why You Should Add DexCom (DXCM) to Your Portfolio Now Zacks
Mar-30-20 06:48PM  Why Soaring Health Industry Stock DexCom is a Strong Buy Right Now Zacks +5.72%
11:30AM  Is DexCom (DXCM) Outperforming Other Medical Stocks This Year? Zacks
Mar-27-20 11:04AM  Coronavirus Stock Market Crash: New Stock Market Leaders Will Share This Common Trait Investor's Business Daily +5.10%
Mar-26-20 10:41AM  Dexcom Investor's Business Daily Video
09:52AM  Stock News: Dow Jones Scores Third Straight Bullish Gain Investor's Business Daily Video
Mar-25-20 08:16AM  US Government Reaches Deal on Stimulus Package: 5 Top Picks Zacks
Mar-23-20 06:55AM  Is DexCom, Inc. (NASDAQ:DXCM) Better Than Average At Deploying Capital? Simply Wall St.
Mar-20-20 05:45PM  DexCom (DXCM) Gains As Market Dips: What You Should Know Zacks
08:16AM  Dow Jones Futures Signal Coronavirus Stock Market Rally Amid Stimulus Hopes; Tesla, Boeing, AMD, Nvidia, Amazon Rise Investor's Business Daily
Mar-19-20 10:35AM  Hedge Funds Have Never Been This Bullish On DexCom, Inc. (DXCM) Insider Monkey +7.89%
Mar-17-20 10:12AM  The Zacks Analyst Blog Highlights: HP, DexCom and Western Digital Zacks
Mar-16-20 11:31AM  New Strong Buy Stocks for March 16th Zacks -17.10%
10:48AM  Dexcom Tumbling Investor's Business Daily Video
Mar-14-20 11:30AM  DexCom (DXCM) Down 3.3% Since Last Earnings Report: Can It Rebound? Zacks
08:00AM  Coronavirus Bear Market: All Stocks Are Under Quarantine, But Keep These Five Under Observation Investor's Business Daily
Mar-13-20 11:30AM  Is DexCom (DXCM) Stock Outpacing Its Medical Peers This Year? Zacks
Mar-12-20 05:45PM  DexCom (DXCM) Stock Moves -1.89%: What You Should Know Zacks
11:52AM  Dexcom Down But Not Out Investor's Business Daily Video
Mar-06-20 08:13AM  Dow Jones Futures Dive: Apple, Tesla, Lead Nine Stocks To Watch In Coronavirus Stock Market Correction Investor's Business Daily
01:05AM  How Lipper Award-winning fund managers are playing coronavirus scare Reuters
Mar-03-20 08:10AM  Dow Jones Futures Reverse Sharply Lower After G-7 Statement; It's Still A Coronavirus Stock Market Correction Investor's Business Daily
Mar-02-20 08:00AM  Look Who's Got Lots Of Leaderboard, IBD 50 Stocks Investor's Business Daily
06:32AM  Why Dexcom, Zoom Video Lead 5 Stocks For Your Watchlist In Coronavirus Stock Market Correction Investor's Business Daily
Feb-28-20 04:54PM  This IBD Stock Of The Day Is Weathering Coronavirus Better Than Its Rivals Investor's Business Daily
Feb-26-20 11:30AM  Is DexCom (DXCM) Outperforming Other Medical Stocks This Year? Zacks
Feb-24-20 04:15PM  Dexcom to Present at Cowen 40th Annual Healthcare Conference Business Wire
09:23AM  Is Dexcom (DXCM) a Great Growth Stock? Zacks
07:33AM  Insulet Partners With Dexcom for Automated Insulin Delivery Zacks
Feb-21-20 04:36PM  Insulet Partners With Abbott and DexCom On Diabetes GuruFocus.com
Feb-20-20 09:21AM  Increased Earnings Estimates Seen for DexCom (DXCM): Can It Move Higher? Zacks
09:18AM  Why DexCom (DXCM) Stock Might be a Great Pick Zacks
08:43AM  Edited Transcript of DXCM earnings conference call or presentation 13-Feb-20 9:30pm GMT Thomson Reuters StreetEvents
Feb-19-20 02:03PM  The Top 5 Buys of Steve Mandel's Lone Pine Capital GuruFocus.com
12:20PM  Why DexCom (DXCM) Might be Well Poised for a Surge Zacks
09:15AM  DexCom (DXCM) Hits 52-Week High, Can the Run Continue? Zacks
07:26AM  Will DexCom Continue to Surge Higher? Zacks
07:00AM  Dexcom and Insulet Announce Commercial Agreement to Integrate the Dexcom G6 and Future G7 CGM into Insulets Omnipod Horizon Automated Insulin Delivery System Business Wire
Feb-14-20 04:37PM  This Leading Diabetes Stock Just Launched Into A Profit-Taking Zone Investor's Business Daily +12.57%
10:12AM  Stock Market Turns Mixed On Retail Sales; Dexcom, Nvidia, Roku Jump On Earnings, But Datadog Plunges Investor's Business Daily
09:04AM  DexCom (DXCM) Q4 Earnings and Revenues Surpass Estimates Zacks
08:43AM  Dexcom Gets Praise from Analysts After Earnings Beat TheStreet.com
08:11AM  Dow Jones Futures: Stock Market Resilient; Nvidia, Roku, Dexcom Lead Key Earnings Movers Investor's Business Daily
06:18AM  Dexcom Prepares for G7 Launch in 2021; Raising Our Fair Value Estimate Morningstar
Feb-13-20 05:25PM  DexCom (DXCM) Q4 Earnings and Revenues Top Estimates Zacks
04:53PM  How This Leading Diabetes Player Rode U.S. Sales To Crush Estimates Investor's Business Daily
04:01PM  Dexcom Reports Fourth Quarter and Fiscal Year 2019 Financial Results Business Wire
08:46AM  The Zacks Analyst Blog Highlights: Waste Management, TC Energy, Duke Energy, DexCom and Republic Services Zacks
08:05AM  The Daily Biotech Pulse: Deciphera Cancer Drug Gets Priority Review, Fast Track Designation For Soligenix, Revolution Medicines IPO Benzinga
Feb-12-20 09:46AM  Medical Products Stock Q4 Earnings on Feb 13: DXCM, LH & More Zacks
09:12AM  Why Earnings Season Could Be Great for DexCom (DXCM) Zacks
08:47AM  5 Must-Buy Corporate Giants Set to Beat on Earnings Tomorrow Zacks
Feb-10-20 09:58AM  Does DexCom, Inc.'s (NASDAQ:DXCM) CEO Salary Compare Well With Others? Simply Wall St.
09:47AM  Can Pharmacy Services Growth Aid CVS Health (CVS) Q4 Earnings? Zacks
08:35AM  Ecolab's Eco-Flex Teat Dip to Boost Food & Beverage Segment Zacks
08:26AM  DexCom (DXCM) to Report Q4 Earnings: What's in the Cards? Zacks
08:12AM  Dow Jones Futures: Stock Market Rally Isn't 'Different This Time'; Tesla Soars Once Again, Apple Falls Investor's Business Daily
07:54AM  Cannabis Therapy to Drive Canopy Growth's (CGC) Q3 Earnings Zacks
05:00AM  Shifting Trends in Diabetes Monitoring Boost Dexcom and Tandem MoneyShow
Feb-07-20 07:42AM  What's in the Cards for DaVita (DVA) This Earnings Season? Zacks
Feb-06-20 12:31PM  DexCom (DXCM) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks
Feb-04-20 11:44AM  What's in the Cards for Exact Sciences' (EXAS) Q4 Earnings? Zacks
07:57AM  BD Life Sciences to Aid Becton, Dickinson (BDX) Q1 Earnings Zacks
Feb-03-20 05:45PM  DexCom (DXCM) Stock Sinks As Market Gains: What You Should Know Zacks
09:15AM  DexCom (DXCM) Hits Fresh High: Is There Still Room to Run? Zacks
Jan-31-20 01:04PM  Best Thematic ETFs for 2020: Cloud, Internet of Things & More Zacks
10:44AM  ABIOMED (ABMD) to Report Q3 Earnings: What's in the Offing? Zacks
10:18AM  Edwards Lifesciences (EW) Q4 Earnings Lag, Sales Top Estimates Zacks
10:16AM  ResMed (RMD) Q2 Earnings Beat Estimates, Margins Expand Zacks
10:00AM  IDEXX (IDXX) Q4 Earnings Top Estimates, Revenues Grow Y/Y Zacks
09:37AM  CONMED (CNMD) Earnings and Revenues Beat Estimates in Q4 Zacks
09:29AM  What's in Store for Cardinal Health's (CAH) Q2 Earnings? Zacks
Jan-30-20 11:15AM  Quest Diagnostics (DGX) Q4 Earnings Beat, Margins Strong Zacks
11:15AM  Hologic (HOLX) Q1 Earnings Meet, Revenues Beat Estimates Zacks
11:11AM  Illumina (ILMN) Q4 Earnings Beat Estimates, Margins Expand Zacks
11:00AM  Thermo Fisher (TMO) Q4 Earnings Top, Organic Growth Solid Zacks
09:07AM  AmerisourceBergen (ABC) Q1 Earnings Beat, Revenues Miss Zacks
09:02AM  Cerner (CERN) to Report Q4 Earnings: What's in the Cards? Zacks
07:06AM  McKesson (MCK) to Report Q3 Earnings: What's in the Offing? Zacks
07:02AM  Varian (VAR) Earnings and Revenues Miss Estimates in Q1 Zacks
07:01AM  Align Technology (ALGN) Earnings Beat in Q4, Margins Rise Zacks
Jan-29-20 11:01AM  Can Solid IC Growth Aid Boston Scientific (BSX) Q4 Earnings? Zacks
08:45AM  Stryker (SYK) Q4 Earnings and Revenues Surpass Estimates Zacks
08:36AM  What's in the Cards for Zimmer Biomet (ZBH) in Q4 Earnings? Zacks
06:09AM  Accuray (ARAY) Q2 Earnings Top Estimates, Gross Orders Fall Zacks
Jan-28-20 10:15AM  Best Growth Stocks To Buy And Research Investor's Business Daily
08:59AM  PerkinElmer (PKI) Q4 Earnings and Revenues Beat Estimates Zacks
08:58AM  Baxter (BAX) to Report Q4 Earnings: What's in the Cards? Zacks
06:35AM  Here's Why You Should Add HealthEquity (HQY) to Portfolio Now Zacks
Jan-27-20 05:45PM  DexCom (DXCM) Gains As Market Dips: What You Should Know Zacks
04:17PM  Stocks To Watch: Medical Stock With 261% Growth Retakes Buy Point Investor's Business Daily
10:10AM  Hill-Rom's (HRC) Q1 Earnings Top Estimates, Revenues In Line Zacks
09:11AM  What's in Store for Thermo Fisher (TMO) in Q4 Earnings? Zacks
Jan-24-20 11:30AM  Is DexCom (DXCM) Stock Outpacing Its Medical Peers This Year? Zacks
09:06AM  Can Critical Care Aid Edwards Lifesciences (EW) Q4 Earnings? Zacks
08:48AM  Can Sequencing Products Aid Illumina (ILMN) in Q4 Earnings? Zacks
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company offers its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, a CGM system for diabetes management; DexCom G5 mobile CGM system to communicate directly to patient's mobile device; DexCom G4 PLATINUM system for continuous use by adults with diabetes; and DexCom Share, a remote monitoring system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop a series of next-generation CGM products; and a collaboration with Companion Medical, Inc. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Selvaraj Shelly RamasamySVP Information TechnologyMar 30Sale271.791,214329,95025,794Apr 01 05:37 PM
Pacelli Steven RobertEVP Strategy and Corporate DevMar 23Sale209.231,531320,33580,532Mar 25 06:22 PM
DOUBLEDAY RICHARDEVP Chief Commercial OfficerMar 23Sale209.271,531320,3969,183Mar 25 06:10 PM
Blackford Quentin S.Chief Operating Officer & CFOMar 12Sale233.556,3531,483,72469,203Mar 13 09:17 PM
Blackford Quentin S.Chief Operating Officer & CFOMar 11Sale264.786,2081,643,72575,556Mar 13 09:17 PM
MOY JEFFREYEVP OperationsMar 11Sale264.766,2031,642,28931,397Mar 13 09:17 PM
Sylvain Jereme MSVP, Finance & CAOMar 11Sale264.83613162,34013,417Mar 13 09:17 PM
Leach Jacob StevenEVP Chief Technology OfficerMar 11Sale264.696,9091,828,756127,498Mar 13 09:17 PM
Pacelli Steven RobertEVP Strategy and Corporate DevMar 11Sale264.828,0492,131,53484,313Mar 13 09:11 PM
Murphy Patrick Michael*Mar 11Sale264.774,0821,080,79430,676Mar 13 09:07 PM
Balo Andrew K*Mar 11Sale264.828,1612,161,23158,588Mar 13 09:29 PM
Abbey DonaldEVP Quality and Regulatory AffMar 11Sale264.688,0502,130,65769,707Mar 13 09:28 PM
ACE HEATHER SSVP Human ResourcesMar 11Sale264.696,2071,642,90238,584Mar 13 09:28 PM
Selvaraj Shelly RamasamySVP Information TechnologyMar 11Sale264.703,387896,52827,008Mar 13 09:20 PM
SAYER KEVIN RPresident, CEO and ChairmanMar 11Sale264.8220,3745,395,432190,016Mar 13 09:17 PM
DOUBLEDAY RICHARDEVP Chief Commercial OfficerMar 11Sale264.748,3032,198,16052,005Mar 13 09:36 PM
Blackford Quentin S.Chief Operating Officer & CFOMar 09Sale261.00891232,55181,764Mar 10 08:19 PM
SAYER KEVIN RPresident, CEO and ChairmanMar 09Sale269.026,0001,614,099210,390Mar 10 07:34 PM
ACE HEATHER SSVP Human ResourcesMar 09Sale269.757,8852,126,95544,791Mar 10 08:56 PM
Selvaraj Shelly RamasamySVP Information TechnologyMar 09Sale261.00439114,57930,395Mar 10 08:29 PM
Murphy Patrick Michael*Mar 09Sale261.00500130,50034,758Mar 10 06:49 PM
Pacelli Steven RobertEVP Strategy and Corporate DevMar 05Option Exercise9.808,92787,48583,551Mar 09 05:11 PM
FOLETTA MARK GDirectorMar 03Sale277.081,000277,07913,147Mar 04 06:42 PM
MOY JEFFREYEVP OperationsMar 02Sale278.10362100,67225,032Mar 03 08:15 PM
DOUBLEDAY RICHARDEVP Chief Commercial OfficerFeb 24Sale277.751,532425,50710,714Feb 26 04:31 PM
Pacelli Steven RobertEVP Strategy and Corporate DevFeb 24Sale277.811,531425,32374,624Feb 26 04:24 PM
Leach Jacob StevenEVP Chief Technology OfficerFeb 18Option Exercise9.7811,458112,059122,563Feb 19 07:53 PM
MOY JEFFREYEVP OperationsFeb 18Sale286.916,5991,893,31825,220Feb 20 06:23 PM
Collins Richard AlexanderDirectorFeb 18Sale284.404,0001,137,6005,304Feb 20 06:17 PM
AUGUSTINOS NICHOLASDirectorFeb 14Sale283.801,812514,2463,230Feb 18 06:58 PM
Murphy Patrick MichaelSVP, Legal AffairsFeb 10Sale240.59500120,29526,447Feb 11 07:53 PM
SAYER KEVIN RPresident, CEO and ChairmanFeb 10Sale242.396,0001,454,367190,937Feb 11 07:48 PM
FOLETTA MARK GDirectorFeb 03Sale237.841,000237,84314,147Feb 05 06:04 PM
DOUBLEDAY RICHARDEVP Chief Commercial OfficerJan 23Sale234.341,532359,00312,246Jan 27 05:13 PM
Pacelli Steven RobertEVP Strategy and Corporate DevJan 23Sale234.321,532358,97176,155Jan 27 05:06 PM
SAYER KEVIN RPresident, CEO and ChairmanJan 13Sale230.626,0001,383,710196,937Jan 15 04:48 PM
Murphy Patrick MichaelSVP, Legal AffairsJan 09Sale235.01500117,50526,947Jan 10 08:03 PM
FOLETTA MARK GDirectorJan 03Sale218.051,000218,05315,147Jan 07 08:49 PM
SKYLER JAY SDirectorJan 03Sale217.8525,8065,621,81630,417Jan 07 08:50 PM
ALTMAN STEVEN RDirectorJan 02Sale218.332,500545,83446,304Jan 06 09:05 PM
Pacelli Steven RobertEVP Strategy and Corporate DevDec 23Sale213.171,532326,57677,687Dec 23 07:42 PM
DOUBLEDAY RICHARDEVP Chief Commercial OfficerDec 23Sale213.021,533326,55813,778Dec 23 07:42 PM
AUGUSTINOS NICHOLASDirectorDec 16Sale206.141,812373,5265,042Dec 16 09:17 PM
KAHN BARBARADirectorDec 12Sale205.149,0001,846,22211,266Dec 16 09:16 PM
Murphy Patrick MichaelSVP, Legal AffairsDec 09Sale224.425,5181,238,34627,447Dec 10 08:42 PM
FOLETTA MARK GDirectorDec 03Sale227.591,000227,59316,147Dec 05 04:22 PM
SAYER KEVIN RPresident, CEO and ChairmanDec 02Sale221.3710,0002,213,684202,937Dec 04 08:04 PM
DOUBLEDAY RICHARDEVP Chief Commercial OfficerNov 22Sale217.561,533333,51915,311Nov 25 07:43 PM
Pacelli Steven RobertEVP Strategy and Corporate DevNov 22Sale217.561,532333,30079,219Nov 25 07:42 PM
Abbey DonaldEVP Quality and Regulatory AffNov 21Sale220.2111,6042,555,32968,946Nov 25 06:20 PM
AUGUSTINOS NICHOLASDirectorNov 07Sale185.291,208223,8306,854Nov 08 08:58 PM
SAYER KEVIN RPresident, CEO and ChairmanNov 04Sale157.5010,0001,575,017212,937Nov 06 06:20 PM
Pacelli Steven RobertEVP Strategy and Corporate DevOct 23Sale152.371,532233,43580,751Oct 25 04:35 PM
DOUBLEDAY RICHARDEVP Chief Commercial OfficerOct 23Sale152.341,533233,53016,844Oct 25 04:35 PM
SAYER KEVIN RPresident, CEO and ChairmanOct 01Sale149.6010,0001,496,001222,937Oct 03 06:40 PM
ALTMAN STEVEN RDirectorOct 01Sale149.172,500372,91648,804Oct 03 06:40 PM
DOUBLEDAY RICHARDEVP Chief Commercial OfficerSep 24Sale155.002,016312,4820Sep 26 08:42 PM
Pacelli Steven RobertEVP Strategy and Corporate DevSep 23Sale155.471,532238,18182,283Sep 25 07:37 PM
Balo Andrew K*Sep 18Sale151.462,386361,38457,916Sep 19 06:46 PM
AUGUSTINOS NICHOLASDirectorSep 16Sale145.491,208175,7528,062Sep 18 06:03 PM
Blackford Quentin S.EVP Chief Financial OfficerSep 10Sale141.2510,3201,457,69169,754Sep 12 04:25 PM
Leach Jacob StevenEVP Chief Technology OfficerSep 09Sale149.864,712706,118111,105Sep 11 09:29 PM
Abbey DonaldEVP Quality and Regulatory AffSep 09Sale149.855,843875,59880,550Sep 11 09:30 PM
DOUBLEDAY RICHARDEVP Chief Commercial OfficerSep 09Sale149.855,843875,59466,821Sep 11 09:28 PM
Murphy Patrick MichaelSVP Legal AffairsSep 09Sale149.862,495373,89732,965Sep 11 09:28 PM
Pacelli Steven RobertEVP Strategy and Corporate DevSep 09Sale149.865,843875,62083,815Sep 11 09:29 PM
SAYER KEVIN RPresident, CEO and ChairmanSep 09Sale149.8614,3222,146,269232,937Sep 11 09:27 PM
MOY JEFFREYSVP OperationsSep 09Sale149.854,601689,47534,869Sep 11 09:45 PM
Balo Andrew K*Sep 09Sale151.569,1071,380,23460,302Sep 11 09:42 PM
Blackford Quentin S.EVP Chief Financial OfficerSep 09Sale149.8611,6861,751,23280,074Sep 11 09:36 PM
ACE HEATHER SSVP Human ResourcesSep 09Sale151.226,415970,07352,676Sep 11 09:32 PM
SAYER KEVIN RPresident, CEO and ChairmanSep 03Sale170.1310,0001,701,274247,259Sep 05 04:16 PM
Balo Andrew K*Sep 03Sale170.00376,29069,409Sep 05 04:16 PM
ACE HEATHER SSVP Human ResourcesAug 23Sale174.807,2431,266,06259,091Aug 26 09:12 PM
DOUBLEDAY RICHARDEVP Chief Commercial OfficerAug 23Sale175.142,016353,0882,016Aug 26 09:12 PM
SAYER KEVIN RPresident, CEO and ChairmanAug 15Sale156.1210,0001,561,167278,100Aug 19 06:20 PM
DOUBLEDAY RICHARDEVP Chief Commercial OfficerJul 23Sale153.562,016309,5704,032Jul 24 06:15 PM
SAYER KEVIN RPresident, CEO and ChairmanJul 08Sale146.256,000877,476288,100Jul 09 06:57 PM
ALTMAN STEVEN RDirectorJul 01Sale151.622,500379,05251,304Jul 02 09:38 PM
Pacelli Steven RobertEVP Strategy and Corporate DevJun 24Sale149.653,116466,30489,658Jun 25 05:21 PM
DOUBLEDAY RICHARDEVP Chief Commercial OfficerJun 24Sale149.622,016301,6266,048Jun 25 05:21 PM
AUGUSTINOS NICHOLASDirectorJun 14Sale146.321,208176,7559,270Jun 17 05:50 PM
Leach Jacob StevenEVP Chief Technology OfficerJun 13Sale145.325,099741,008115,781Jun 14 05:32 PM
Murphy Patrick MichaelSVP Legal AffairsJun 10Sale127.0340050,81235,460Jun 11 06:12 PM
SAYER KEVIN RPresident, CEO and ChairmanJun 10Sale132.746,000796,444294,100Jun 11 06:12 PM
Balo Andrew K*Jun 05Sale125.007,825978,12569,392Jun 06 05:35 PM
Abbey DonaldEVP Quality and Regulatory AffJun 03Sale121.089,0301,093,35286,393Jun 04 05:37 PM
Blackford Quentin S.EVP Chief Financial OfficerMay 29Sale118.958,8741,055,52791,740May 30 04:56 PM
DOUBLEDAY RICHARDEVP Chief Commercial OfficerMay 23Sale117.292,016236,4528,064May 24 05:09 PM
Pacelli Steven RobertEVP Strategy and Corporate DevMay 23Sale116.713,597419,81692,774May 24 05:09 PM
FOLETTA MARK GDirectorMay 15Sale121.891,000121,89513,095May 17 06:22 PM
SAYER KEVIN RPresident, CEO and ChairmanMay 13Sale115.736,000694,365300,100May 14 06:47 PM
Murphy Patrick MichaelSVP Legal AffairsMay 10Sale116.9240046,76835,860May 13 05:51 PM
Leach Jacob StevenEVP Chief Technology OfficerApr 24Option Exercise7.274,79734,874120,880Apr 25 06:06 PM
DOUBLEDAY RICHARDEVP Chief Commercial OfficerApr 23Sale116.982,016235,83810,080Apr 24 07:58 PM
Pacelli Steven RobertEVP Strategy and Corporate DevApr 23Sale116.613,596419,32996,371Apr 24 07:58 PM
FOLETTA MARK GDirectorApr 15Sale118.981,000118,97714,095Apr 17 05:20 PM
SAYER KEVIN RPresident, CEO and ChairmanApr 15Sale118.916,000713,471306,100Apr 16 05:37 PM
Murphy Patrick MichaelSVP Legal AffairsApr 10Sale115.0540046,02036,260Apr 12 05:50 PM
open in yahoo | open in reuters | open in google